Approval · Notice of Compliance 33392 · 2024
CEFTIN: Notice of Compliance 33392
Issued June 4, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33392
- Date
- June 4, 2024
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph (pm) initiated by the sponsor for safety reasons
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFTIN | Not yet assigned | — |
Medicinal ingredients
- CEFUROXIME AXETIL 125 MG per 5ML